Skip to main content
. 2020 Apr 14;10:6398. doi: 10.1038/s41598-020-62193-7

Figure 4.

Figure 4

Decreased syncytin-1 EV signal in maternal circulation enables diagnosis of preeclampsia with high accuracy. (A) Syncytiotrophoblast EVs were quantified on the nanoparticle detector using anti-syncytin-1 antibody conjugated quantum dots. This demonstrated that preeclampsia subjects had lower levels of syncytin-1 expressing EVs compared to control subjects. NanoSight panels show syncytin-1 positive EV subpopulation (red) in relation to total plasma EV pool (blue). (B) Scatter plot analysis of STEV signal showed significantly decreased syncytin-1 signal in preeclampsia subjects (p = 2.82 × 10−11). (C) Receiver operating characteristic curve (ROC) in a binary cohort of preeclampsia versus control subjects was constructed for syncytin-1 EV signal, total plasma EVs quantity, and mean plasma EV size. This demonstrated an area under the curve of 0.975 ± 0.020 for STEV quantitative profiling, and a syncytin-1 EV signal threshold level of <0.316 predicted preeclampsia in this cohort with 95.2% sensitivity and 95.6% specificity. Total plasma EV numbers and mean plasma EV size had low diagnostic accuracy compared to STEV signal quantitation.